Blue Fin Capital Inc. Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Blue Fin Capital Inc. lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 864 shares of the medical equipment provider’s stock after acquiring an additional 64 shares during the period. Blue Fin Capital Inc.’s holdings in Intuitive Surgical were worth $291,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. Vanguard Group Inc. grew its position in Intuitive Surgical by 0.7% during the 3rd quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock worth $8,730,184,000 after purchasing an additional 196,316 shares during the last quarter. Jennison Associates LLC lifted its stake in shares of Intuitive Surgical by 6.4% in the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock valued at $1,340,205,000 after purchasing an additional 274,692 shares during the period. Fisher Asset Management LLC lifted its stake in shares of Intuitive Surgical by 2.0% in the 4th quarter. Fisher Asset Management LLC now owns 4,494,373 shares of the medical equipment provider’s stock valued at $1,516,222,000 after purchasing an additional 88,977 shares during the period. Invesco Ltd. raised its position in Intuitive Surgical by 6.6% during the third quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock worth $1,096,231,000 after acquiring an additional 232,205 shares during the period. Finally, Northern Trust Corp raised its position in Intuitive Surgical by 3.4% during the third quarter. Northern Trust Corp now owns 3,514,421 shares of the medical equipment provider’s stock worth $1,027,230,000 after acquiring an additional 115,059 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $375.39, for a total value of $141,146.64. Following the completion of the transaction, the executive vice president now owns 5,507 shares in the company, valued at $2,067,272.73. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Monday, April 29th. The shares were sold at an average price of $375.39, for a total transaction of $141,146.64. Following the completion of the sale, the executive vice president now owns 5,507 shares of the company’s stock, valued at approximately $2,067,272.73. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Marshall Mohr sold 108,790 shares of the business’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the completion of the transaction, the vice president now directly owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The disclosure for this sale can be found here. Insiders have sold a total of 226,928 shares of company stock valued at $87,833,828 over the last three months. 0.90% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ISRG. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Truist Financial boosted their target price on Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Finally, Piper Sandler lifted their target price on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research report on Friday, April 19th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Intuitive Surgical Stock Up 1.0 %

Shares of ISRG traded up $3.71 during mid-day trading on Friday, reaching $381.36. The company’s stock had a trading volume of 1,028,858 shares, compared to its average volume of 1,492,254. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The business has a fifty day moving average of $385.40 and a 200 day moving average of $349.30. The company has a market cap of $135.27 billion, a price-to-earnings ratio of 68.84, a price-to-earnings-growth ratio of 4.93 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business’s revenue was up 11.5% compared to the same quarter last year. During the same period last year, the company earned $1.00 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.